The Food and Drug Administration (FDA) has approved the use of Baytril® 100 (enrofloxacin) in dairy replacement heifers less than 20 months of age.
Baytril 100 is a powerful, fast-acting antimicrobial for first-line treatment of BRD that beef cattle producers and bovine veterinarians have relied on for more than a decade. This lifesaving antimicrobial kills all three major BRD-causing bacteria with a single dose.
Producers and veterinarians know there is no time to wait when a calf has BRD, especially valuable dairy replacement heifers. With the value of these heifers at an all-time high, Baytril 100 provides a new, fast-acting, broad-spectrum BRD therapy option. Now, for the first time, dairy producers have access to the premier fluoroquinolone class of antimicrobials.
“The introduction of Baytril 100 into the dairy replacement heifer market gives producers and veterinarians access to the premier single-dose, first-line BRD therapy,” says Dr. Cary Christensen, Senior Director, Food Animal Products Business Unit at Bayer Animal Health. “We recognize that a significant number of dairy heifers will need BRD therapy each year. Baytril 100 will not only help save the lives of these animals, but will help ensure their lifetime value is not compromised by the effects of BRD during the first 20 months of life.”